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Abstract 
 
Traditional medicine refers to health practices, approaches, knowledge and beliefs incorporating plant, animal and 
mineral based medicines, spiritual therapies, manual techniques and exercises, applied singularly or in combination to treat, 
diagnose and prevent illnesses or maintain well-being. In the last decade traditional medicine has become very popular in 
Cameroon, partly due to the long unsustainable economic situation in the country. The high cost of drugs and increase in drug 
resistance to common diseases like malaria, bacteria infections and other sexually transmitted diseases has caused the 
therapeutic approach to alternative traditional medicine as an option for concerted search for new chemical entities (NCE). 
The World Health Organisation (WHO) in collaboration with the Cameroon Government has put in place a strategic platform 
for the practice and development of TM in Cameroon. This platform aims at harmonizing the traditional medicine practice in 
the country, create a synergy between TM and modern medicine and to institutionalize a more harmonized integrated TM 
practices by the year 2012 in Cameroon. An overview of the practice of TM past, present and future perspectives that 
underpins the role in sustainable poverty alleviation has been discussed. This study gives an insight into the strategic plan and 
road map set up by the Government of Cameroon for the organisational framework and research platform for the practice and 
development of TM, and the global partnership involving the management of TM in the country. 
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Introduction  
 
Cameroon has about 90% of the African ecosystems which includes; the Sahelian, Sudan, humid tropical forest, 
afro mountains, coastal and mountain eco-regions. There is a significant diversity of flora and fauna and ranks the 5th in 
Africa after the republic of Congo, South Africa, Madagascar and Tanzania (Letouzey, 1985; Cunningham, 1993). This rich 
biological biodiversity is associated with the diversity of the ethnic groups in which each contributes a unique ethno 
pharmacopoeia and to Cameroon a national therapeutic patrimony, which is the richest in Africa (Houhgton 1995; 
Nkongmeneck et al., 2007). 
 
Priorities for promoting use of TM in cameroon. 
 
In Cameroon the advent of economic crisis in the late 1980 has created a shift  towards consumption of medicinal 
plant as an increasing practice in herbal medicine. In order to integrate TM into the national healthcare system of Cameroon 
the WHO in collaboration with the Cameroon Government has put in place strategic route map for TM integration by 2012 
(Burkhill, 2000; Ngadjui et al., 2000). The limited scientific evidence about TM/CAM’s safety and efficacy as well as other 
considerations make it important for governments to step into the TM practice, research and development within the frame 
work of integration into the primary, communal and the national health care system in Cameroon (Noumi, 1984, CIFOR, 
2005; Nkongmeneck et al., 2007). 
 
Traditional Medicine platform in Cameroon 
 
The focus of the implantation strategies for the promotion of traditional medicine research, development and 
practice in Cameroon is as follows; 
1-Formulation of national policy and regulation for the proper use of TM/CAM and its integration into national health care 
systems in line with the provisions of the WHO strategies on Traditional Medicines; 2-Establish a regulatory mechanisms to 
control the safety and quality of products and of TM/CAM practice; 3-Create awareness about safe and effective TM/CAM 
therapies among the public and consumers; 4-Cultivate and conserve medicinal plants to ensure their sustainable use. 5- 
Develop national policies on the evaluation and regulation of TM/CAM practices; 6-Create a stronger evidence base on the 
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safety, efficacy and quality of the TAM/CAM products and practices; 7-Ensure availability and affordability of TM/CAM 
including essential herbal medicines; 8-Promote therapeutically the sound use of TM/CAM by providers and consumers; 9-
Document traditional medicines and remedies (Nkuinkeu et al., 2007; Jiofack et al 2008) 
 
Interest in medicinal plants and phytomedicines in Cameroon 
 
Although the main consumers of medicinal plants in Cameroon have been, until recently, the local population, the 
field has started to attract a number of local and foreign researchers who have discovered the value of traditional healing 
(Jiofack  and Ayissi, 2006; IUCN, 2007) There is active development in TM most especially in the West and Northwest 
regions of Cameroon where there is an amalgamation of tradi-practitioner to create strong regional associations and organs of 
operation. Early studies were undoubtedly on ethno-botanical survey and exploration, but since the 90s’ the fields of study 
have expanded to include ethno-pharmacology, phytochemistry, chemistry of natural products, organic synthesis and the 
usefulness of medicinal and aromatic plants. (Nkuinkeu, 1998; Calapai and Caputi, 2007; Jiofack et al 2009) This interest has 
increased over the years because of the effort the state has put into natural product research through the University post-
graduate research programmes and the Ministry of Research and Innovation’s natural products research and development 
(CERUT, 1999; Nkuinkeu, 2000; Kuete et al., 2007). Some selected medicinal plants for the treatment of malaria under 
ongoing research for new chemical entities have been shown in figure 1, and 2 the destruction of medicinal plants through 
abusive harvesting is also highlighted.  
The pharmaceutical industry has come to consider traditional medicine as a source for identification of bio-active 
agents that can be used in the preparation of synthetic medicine. However, they are not looking to study the rare plant species; 
they want to test the most commonly-used species (LeBeau, 1998; Nguenang et al., 2005; Khan et al., 2009). The valuable 
medicinal plants are those with the longest track record of use in most or wider locations or distribution in Cameroon 
(Cunningham, 1993; Nkongmeneck et al., 2007). Many of the more commercial pharmacologically interesting medicinal 
plant species in use around the world are employed in more than one community, and often in more than one country, for 
multiple uses (Dooley et al., 2008; Focho et al, 2009).  
 
Cameroon Traditional Herbal Medicine and Public Health Sector 
 
The majority of African countries and Cameroon in particular, as the case may be, are currently geared towards the 
privatisation of State corporations and government services. This includes the privatisation of large hospitals where goals of 
financial independence have precluded the dispensation of free care and free medicine (Nkuinkeu 2000, Mbile et al., 2003, 
MINSANTE, 2007). Analysis of various national policies related to public health and medicinal plants usage has highlighted 
some important issues. Among them is the failure to meet basic health conditions due mainly to the following factors in 
Cameroon: inadequate decentralisation of health services; isolation of some rural communities; and persistence of traditional 
beliefs regarding pathology (IUCN, 2007). This has led to underutilisation of available services in health centres and high 
cost of services provided by hospitals in relation to the income of the rural population (Comesky and Sunderland, 2003). 
Another issue that can be singled out is the absence of local pharmaceutical production. Since the ‘60s since Cameroon had 
its independence, the country has not been blessed with a single Drug discovery owned by the state. Purchase of 
pharmaceutical imported drugs lead to a heavy loss of state revenue, and the development policy has not been focused on 
available local resources (mainly medicinal plants) (Human and Weerdenburg, 1985; Jiofack and Ayissi, 2006). The current 
trend of government policy in Cameroon to pay for the health care services shows the inability of government to ensure 
provision of quality services at an affordable price to everyone and especially to the most vulnerable groups (Mbile et al 2003; 
Cheek et al., 2004).  
In the rural areas of Cameroon, one sometimes travels for several days before finding the nearest dispensary and 
pharmacy or health clinic for consultation. In addition to loosing working days, transport fares the high cost of medicine must 
also be taken into consideration. In the past few years, Cameroon joined most of the developing countries in recognising that 
they do not have the means to provide comprehensive health care like some industrialised countries, and have started taking 
more interest in promoting the use of traditional remedies (Duncan 1989; Sunderland et al., 2002; Jiofack et al.,  2007). 
In order to solve the problem of drug shortage or high cost in part, many health-oriented ministries are now encouraging the 
use of local medicinal plants for disease treatment. The Cameroon ministry of health have established departments of 
traditional pharmacopoeia within the ministerial organigram so as to implement this policy of TM. Education ministries, the 
Ministries of Forestry and Wildlife, Research and Innovation have started to introduce conservation and bio-diversity of 
medicinal plants into their school programmes and the general sensitization of the population (Nkongmeneck et al., 1996; 
Nguenang et al., 2005. The recent establishment of the Ministries of Environment and Nature Protection and the creation of 
National Parks, and mapping of protected forest areas, in various parts of the country also demonstrates the political will of 
the Cameroon governments towards the conservation of nature and the sustainable management of bio-diversity (Vivien et al., 
1985; Nkuinkeu et al., 2007). 
The lack of health care systems in rural areas forces local people to treat themselves, either by using medicinal 
plants or by buying high-cost medicine in the rural markets, or still further, going for cheap road side medication, 
predisposing themselves to health dangers caused by the unknown source of these poor medications (Ndhlala et al., 2009). In 
the rural areas, as a whole, people begin by treating themselves before going to a traditional practitioner or a modern doctor. 
Medicinal plants are used at an early stage of the disease at low cost and conveniently replace the indiscriminate consumption 
of drugs without prescription. (Fokunang et al., 2000; Horan et al., 2003; Oyama et al., 2009). 
Many Cameroonians today, especially the rural people and the urban poor, rely on the use of herbal medicine when 
they are ill. In fact, many rural communities in Africa still have areas where traditional herbal medicine is the major and in 
some cases the only source of health care available (Bloom et al., 2002; Derita et al., 2009). Thus there can be no doubt about 
the acceptability and efficacy of herbal remedy within African society.  
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How the Western Medical Systems has declined in Cameroon 
 
In some urban areas the average waiting time at a hospital or clinic to consult a doctor can be as much as 8 hrs. -
The staff is poorly trained and unmotivated. Many staff members believing they hold superior knowledge, treat patients 
inconsiderately.-Patients are frequently not told the nature and cause of their illness. -There are inadequate technical services 
leading to poor quality care. -The treatment costs in clinics are too much, even for state run hospitals and clinics, where 
consultation and treatment is assumed subsidized. The doctor to patient ratio is approximately 1: 150 per day in the national 
territory. -Government spends a large proportion of the Per Capita gross national product on western health care (Sofowora, 
1982; Bloom et al., 2002; MINSANTE, 2007). -Treatment is divorced from the patient’s culture; family and community. 
Patients are removed from the family and community, stripped of their identity and forced into a sterile hospital setting. The 
treatment only addresses a patient’s biological manifestation of the illness and does not attempt to heal spiritual aspects of 
illness. This is the place and the role of traditional medical practitioners, in contrast with western medicine, which is 
technically and analytically base (Tuley, 1997; Samy et al., 2008).  
It is difficult to characterize a typical Cameroonian healer, because there are many different kinds, and the cultural 
diversity and complexity of their practices are encyclopaedic, when considered in detail. Most Cameroonian healers have in 
common, however, that they describe and explain illness in terms of social interaction and that they act on the belief that 
religion permeates every aspect of human existence (CERUT, 1999; Tongo, 2003).  
Their concepts of health and illness are more comprehensive than those of biomedical doctors. Other prominent 
features of traditional healers are a deep personal involvement in the healing process, the protection of therapeutic knowledge 
by keeping it secret, and the fact that they are rewarded for their services. The social context of the therapeutic process 
requires reciprocity and this payment contributes to the effectiveness of the treatment. (Owira and Ojewole, 2008; Jiofack et 
al., 2009) 
 
Traditional Practice fee in Cameroon. 
 
Over the years, the types and methods of payments for traditional healing have changed. In urban settings, 
practitioners are increasingly demanding monetary payments. Some healers have learnt their trade by undergoing treatment 
themselves as a patient. The magical inclination of Cameroonian traditional medicine takes nothing away from the fact that 
some of the healers now are days, are experienced and skilled in biomedical components of their profession. They have an 
array of biomedical methods at their disposal, ranging from fasting and dieting to herbal therapies and from bathing and 
massage to surgical procedures (Kokwaro, 1993; Pedersen et al., 2008). Some of the practitioners are graduates who have 
undergone third level education in the sciences and biomedical sciences. Through hardship, economic downturn and lack of 
employment in state structures, some educated young Cameroonians have resulted in learning through workshops and short 
training some ethno-botanical and ethno-pharmacology techniques of medicinal plants. There has been a tendency in Western 
medical journals to play down the expertise of African healers by predominantly presenting the iatrogenic risks of their 
traditional therapies. It cannot be denied, of course, that sometimes there is genuine cause for concern (Stafford et al., 2008). 
It would be unfair, however, to pass judgement on the biomedical merits of African traditional medicine on the basis of its 
worst outcomes. Instead, African healing should be considered with a sympathetic eye and with emphasis on its best 
biomedical manifestations (Noumi, 1984; Ngameni et al 2007). Urbanization has increasingly concentrated large numbers of 
Cameroonian traditional healers and practitioners in an environment where there is stronger competition with the Western 
medicine. Traditional healing is flourishing in urban settings because it adapts itself to these new surroundings (Robbers et al., 
1996). In other words, Cameroonian traditional medicine is more than a static and inflexible institution, which cannot survive 
the test of time. When a Cameroonian patient is taking an herbal infusion, he expects to benefit from the life force of its 
ingredients and from the power of his ancestors of any other spirits which may have been invoked. This spiritual significance 
is more important than the bioactive properties of the remedy.  
 
WHO-Cameroon collaboration to valorize TM. 
 
The WHO and the Government of Cameroon has signed a convention to draw up a strategic plan for the 
valorisation to TM in Cameroon. However, despite this programme in progress, the sector is plague with numerous 
constraints relating to the development of traditional medicine that can be summarised as follows: The lack of  institutional 
support for production and dissemination of key species for cultivation; The low prices paid for traditional medicinal plants 
by herbal medicine traders and urban herbalists; Lack of appropriate technology for post harvest and pre-processing purposes 
adapted productively and effectively; Insufficient documentation and scientific experimentation for verification of the 
herbalist’s claims; Lack of preservation of medicinal extracts for extended shelf life (MINSANTE, 2007; Jiofack et al., 2009). 
The National Strategic Plan for the development and integration of Traditional Medicine in Cameroon and other member 
countries by the WHO in general and the Africa Union in particular, adhere to the recommendation of the organization to 
valorise traditional medicine. The political engagement of Cameroon is strongly translated by the official recognition of TM 
as one of the three main health sectors. The main players of the government convened to put a strategy for the development 
and integration of traditional medicine in the health system within the framework of the millennium development goal in 
reducing poverty, morbidity and mortality and sustainable health care development (Tuley de Silva, 1997; MINSANTE, 
2007). Medicinal plants are sold locally as plants parts, in powder, dry bark of tress in solutions as shown in Figure 3.  
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Organization of Health Care in Cameroon. 
 
The health system in Cameroon is organised in three levels, represented in the form of pyramid. At the summit is 
the Central level, the intermediate and the operational level at the base. Three types of structures are integrated into each level 
namely: the administrative and finance healthcare and community participation (dialogue structure) 
The Central Level: The administrative and management structures are represented by the minister of Public Health. The 
health care structures consist of the three general and reference hospitals, a university teaching hospital and four assimilated 
central hospitals.  
The Intermediate Level: The administrative and management levels consist of the ten regional delegation of public health. 
The health care structures consist of nine regional hospitals and affiliate structures and the communication structures are 
made of the regional management commission or regional funds. 
The Operational Level: The administrative structures and management structures consist of 173 District health services. The 
existing structures have 154 district public hospitals, 87 private hospitals, 148 divisional health centre, 1700 health centres 
and 620 private health centres  
The Traditional Medicine Sub-Sectors: Currently Cameroon have at all levels, a non -structured or poorly organized 
organogramme of TM.  
The conference of Regional Governors organized in 1976, by the Ministry of Public 
Health for putting an Organizational structure to valorize TM permitted the establishment of 3 organs in Operation such as: 
1-The National Commission for TM, in charge of helping the government in the definition and exploitation of TM;  
2-Permanent committee of TM in charge of coordinating the research activities and practice of TM; -3-The Medical Institute 
for the study of medicinal plants in charge of operational research. The Political engagement was validated by the ministerial 
decision No 031/D/MSP/DS/BT of 31 July 1979 creating and organizing the TM sector within the jurisdiction of the Ministry 
of Public Health. (MINSANTE, 2007). 
The decree of 4th December 1979 organizing the General Delegation for technical and scientific research (DGRST) 
formerly known as National Office of Technical and Scientific Research (ONAREST)-IMPM was created in 1974. IMPM 
was charged with the responsibility of drawing up a realizable research programme on TM in order to improve on the health 
conditions of Cameroonians. The IMPM Institute have four centre of which the Centre for the study of medicinal plants 
(CEPM) was aimed at elaborating a research programme geared towards the production of drugs and adequate therapeutics 
using local natural substances. The creation of a traditional medicine unit at the Central Hospitals of Yaoundé, took place in 
1981. The organization of the organigramme of the Ministry of Public Health integrating a service for community health and 
TM under the tutelage of Preventive and Rural medicine happened in 1989. The launching of the first seminar/workshop on 
TM and Cameroonian pharmacopoeia in the medical school (CUSS), Yaoundé took place from the 10-14th July 1989.  
The creation of association of TM enacted by the freedom of association law No 90/053 of 19 December 1990 was followed 
by a circular note No: D26/NC/MSP/SG/DMPR /DAMPR/SDMR/SSCMT of 16th September 1991 authorizing conventional 
medicine to collaborate closely where possible with tradi-practitioners. The decree No. 93/215 of 4 August 1993 authorized 
the reorganization of IMPM and changing the name from. CEPM to CRPMT (Centre de Recherche en Plantes Médicinales et 
en Médicines Traditionnelles). Then came the prime ministerial decree No 98/405 PM, fixing the homologation strategy to 
put in the market pharmaceutical products. This led to the creation of the National Drug Commission, which harbours the 
Commission specialized in Pharmacovigilance and traditional pharmacopoeia; secondly the Commission specialized in 
Phytotherapy and alternative therapeutic techniques. The presidential decree no 2002/209 of August 2002 organizing the 
Ministry of Health, put in place a sub-directory in charge of Primary Health, the service of traditional social-health care, 
made of the office of Ethics and Social Health care deontology, and the bureau of Welfare and Legislation Control. This 
decree also created a division of Operational Research made up of Scientific Network Cells in charge of support in medicinal 
plant research (MINSANTE, 2002). Local initiatives are in progress by different NGO’s and the state Institutions to train 
tradi-practitioners the basic conservation techniques and preparation of their herbs within the frame work of quality assurance 
as shown in Figure 4. 
 
Commemoration of African Traditional Medicine day in Cameroon 
 
African Traditional Medicine Day is celebrated every year in Cameroon, to sensitized the public on the importance 
TM. This is a coordinated effort of the government through the Ministry of Health, Ministry of Forestry and Wildlife, 
Ministry of Research and Innovation and the Ministry of Higher Education, in synergy with tradi-practioners, and medicinal 
plant researchers involved in contributing to the progress and promotion of traditional medicine in Cameroon. This 
celebration takes place each year on the 31st August, marking an event where there is collaboration between Traditional and 
Biomedical Health Practitioners. Each year a theme is given for the celebration, such as “the role of traditional health 
practitioners in primary health care management” Round table discussions are organized to deal with TM issues, such as the 
need for synergy between groups, the medical practitioners, ethical issues, health concerns in the practice of TM.  
 
Limiting factors of TM practice collaboration in Cameroon. 
 
One of the main problems that have caused a slow collaboration between medics and Tradi-pratitioners is the lack 
of legal framework and official recognition of TM by conventional medicine. (UNESCO, 1994; White, 2000;Tiwari et al., 
2009). Tradi-pratitioners are not accepted but tolerated because of the decree that has created a harmonization of the primary 
health care involving all stake holders. There are no laws guiding the TM practice in Cameroon. The TM sector is volatile 
and isolated and uncensored, and anyone can enter the trade and this has consequently led to breeding quacks or what is 
known as “charlatans”. There are also competitions in the trade between medics and tradi-practitioners for patients, “thus the 
saying goes that the winner takes it all”. The party with provisions of the best incentive gets the patients. Lack of proper 
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integration of traditional medicine in health care systems: Traditional healers are not attached to bodies like the malaria or 
HIV/AIDS control committees, they are not involved in the running of services in charge of their work in the ministry of 
health, are not attached to top research centres, and are rarely given the opportunity to consult in health care institutions as in 
other countries in Africa. (Mabberly, 1987; Ngadjui, 2000; Kuete et al., 2007; Xu et al, 2008). 
We cannot deny the drawbacks of traditional medicine, which include incorrect diagnosis, improper dosage, and 
low hygiene standards, the secrecy of some healing methods and the absence of written records about the patients (LeBeau, 
1998;Teklehaymanot, 2009). Most of the time, the practitioner are unable to have a limit on what they can cure. There is a hit 
and miss operation going on most of the time. They have very little knowledge on drug-herbal interactions. This had led to 
severe problems in patients during or after treatment outcomes. Though there is certainly cause for concern, it is unfair to 
pass judgement on the Cameroon TM healing systems on the basis of their worst outcomes; concerns about romanticising the 
traditional practices have to be taken seriously (Nkongmeneck et al., 2007; Zhou et al., 2009) 
 
Improving collaboration between Medics and Tradi-Practitioners. 
 
Traditional medicine should be officially legalised and made part of the official health care system in Cameroon. 
Intellectual property rights protection should be extended to traditional medicine because some of them have treasured 
products they have worked with over generation and need to be supported for protection rights. Government should openly 
and effectively support scientific research into traditional medicine therapies. Traditional medicine should be officially 
legalised and made part of the official health care system in Cameroon. Government should openly and effectively support 
scientific research into traditional medicine therapies . 
 
Medicinal Plant Research by State Universities 
 
Many medicinal plants with antimicrobial activities, anti-inflammatory, anti-oxidant, anticancer, anti-diabetic etc of 
pharmaceutical importance in developing new chemical entities (NCE), have been phyto-chemically screened and 
characterized by natural product chemist; and activities tested by biochemist, toxicologist and pharmacologist, in animal 
models (in vivo), cell lines, pathogen (bacteria, fungi, viruses), parasites (malaria Plasmodium, sleeping sickness 
(Trypanosome) and many others ((Hepinstall et al., 1992; Kuete et al., 2007; Garrido et al., 2009). Some of these research 
have produce good results leading to clinical trials that have shown confidence in safety, efficacy and good pharmacokinetics 
and pharmacodynamics parameters for a potential drug (Pernham, 1996; Mann and Staba, 1998; Asongalem et al., 2008 . The 
outcome of continuous research has led to some  progress in research and development of lead compounds that are under 
clinical trials in Cameroon from some natural products such as Enantia chlorantha that had produced drugs marketed under 
the brand name HEPASOR, used for hepatitis virus treatment (Nkongmeneck, 2007). The success story of drugs from 
medicinal plants commercially available in the market is illustrated in Figure 5. 
 
Hepasor from Natural Plant Enantia chlorantha 
 
Hepasor is used for the treatment of viral hepatitis family. After submission to the Cameroon drug and pharmacy 
board for approval, HEPASOR was authorized to be put on the list of essential drugs in Cameroon by the Ministry of Public 
Health and it is prescribed as an oral solution in a 250 ml bottle (Nkongmeneck, 2007). The hepatitis virus can vary from one 
geographic region to another and within individual and population. Following the geographic distribution of viral hepatitis, 
Africa is the most affected continent with a prevalence rate of 12.7%. Viral hepatitis has been a health concern for a long 
time due to lack of specific efficacious drugs. On the curative front many therapies has been used but most of the drugs have 
been known to be hepatoprotectant. The stem bark of E. chlorantha is very popular for the treatment of viral hepatitis in the 
forest zones of Cameroon (Jiofack et al., 2009). 
The active compound of a complex alkaloid protoberberine isolated from the stem bark of E. chlorantha is 
constituted of 65% palmatine, 20% jatrorrhizine and 15% cohumbamine.  In a natural synergistic manner these alkaloids 
have shown a curative and preventive function on viral hepatitis. Toxicity test on protoberine active molecule have shown 
that in addition to its antimicrobial activity, hepasor stimulate blood circulation, regenerates hepatocytes and regulate the 
normal hepatic functions, thus eliminating megalocytosis. 
The therapeutic dose of hepasor is not toxic and the LD50 of protoberberine is 320mg /kg of body weight. No side 
effect was observed on increase in body weight, blood, hepatic, renal tissues and central nervous system. On the contrary 
secondary beneficial effect was observed: Hepasor is a general tonifiant and appetizer ( http://ekolab.free.fr). 
Clinical pilot studies showed improvement of the clinical symptoms on day 7 and there were no symptoms of hepatitis virus 
after 30 days of treatment. Other biochemical parameters such as bilirubine and transaminase levels were restored to normal 
level at 60 days of treatment.  
 
Multilateral Research cooperation in Cameroon. 
 
The Scientific Technical Research Committee of OAN now, AU, (OUA/CSTR) and the agency for Cultural and 
Technical Cooperation co-financed an ethno-botanical survey in collaboration with the national and international researchers. 
This had led to the collection and building up of a strong data base on 600 Cameroonian medicinal plant inventory, that has 
served as the starting point for many chemical, biochemical, toxicology and pharmacological clinical and drug formulation 
studies (CERUT, 1999; IUCN, 2007). In recent years research laboratories have gone into partnership cooperation with 
partners of the West, through their various university host institutions, on multidisciplinary research projects in medicinal 
plants. Some of their findings are in advance stages of clinical trials; most especially in the areas of anti-diabetics, 
hypertension, anti-oxidant research (Human and Weerdenburg, 1985).  
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Local industries producing drugs from medicinal plants. 
 
There are success stories in medicinal plant research, the journey from the forest, clinics to the pharmacy.Three 
private industrial firms were created and produces drugs from plant origin that are now sold in pharmacy and drug outlets in 
Cameroon.  
These companies are: 
1-LOBOTHERA Laboratory produces the syrup HEPASOR used for treatment of viral hepatitis . 
2-KAMSU-KOM Laboratory produces POLA-GASTRAL A-T-200 syrup used for the treatment of stomach ulcer and 
inflammations. 
3-AFRICAPHARM laboratory produces anti –hemorrhoid syrup (syrup Gama) 
The organization of traditional medicine practice will bring about a controlled practice and a more responsible and 
harmonized team of tradi-practitioners. Their integration into the national health sector will bring about putting in place at the 
disposal of the public standardized traditional medicines, with standard affordable prices as a means of fighting poverty. 
Tradi-practitioners are integrated and well respected people in their communities. With this standing in society they can play 
a vital role in the community social health information and health care sensitization.  
Cameroon has a rich diversity of flora as a potential to produce primary materials for phyto-medicines. Traditional 
pharmacopoeia provides avenues for enriching research for new chemical entities that could lead to production of medicines 
for use in different therapeutic areas such as HIV/AIDS, tuberculosis, malaria, sickle cells and other neglected diseases 
plaguing the communities and of public health concern.  
 
Ethical issues on TM practice in Cameroon. 
 
On the ethical point of view there is complete absence of the code of conduct in the practice of TM. This has led to 
abuse of significant magnitude Uses and sale of products without any instruction or inset and poor labeling. Sales of products 
without any scientific studies on the active principles and safety (Zhou et al., 2009).  Lack of any norms to control what is out 
in the market for consumption. No formal structure or organization to train tradi-prationers on basic therapeutic techniques 
and handling of medicinal plant products. Lack of any documentation system, data base for information on medicinal plants, 
conventions, treaties and decree on medicinal plants (IUCN, 2007; Jiofack et al., 2007).  
 
Economic problems in Cameroon. 
 
On the economic point of view the over-exploitation of medicinal plants by tradi-practitioners and forest exploiters 
have impacted a serious consequent on the environment and conservation of species. The lack of political will to support the 
development the capacities of local industries. The culture of fundamental ethics and patenting is not known or under 
exploited in Cameroon. The absence of any frame work of collaboration between the TM authors and custodian of 
knowledge of plants and industrial partners. The low purchasing power of the public on medications, faced with the long 
financial hardship that the country has witnessed since the early 90’s, and the lack of health care facilities in the remote parts 
of the country (Abegaz, 1999; CIFOR, 2005; Akintonwa et al., 2009) 
 
Fundamental problems. 
 
Some fundamental problems on plant medicinal research are due to the fact that some indigenous researchers 
publish their works without any intellectual property rights. The level of protection of innovation and inventions in plants 
medicines is in total contradiction with the potentials of traditional pharmacopoeia, the knowledge of traditional medicine 
and dynamism of researchers (Bodeker, 1994; Achoundong et al., 2003). The lack of state of the art equipment to promote 
research and development, quality control and quality assurance of TM. There is also the problem of training and research 
that needs to be address. Teaching of TM is not an official institutional programme in training school of health personnel.  
TM in Cameroon is still essentially under observation and on a personal experience basis, buried in the socio-cultural fabrics 
and particularly geared towards the ethics and metaphysics beliefs of the African folks (Anonymous, 2000; Agyare et al., 
2009). The total lack of spirit for traditional medicine research. The existing bodies or association governing 
tradipractitioners do not collaborate and are poorly structured and managed. The absence of a national umbrella to coordinate 
and intervene in the harmonious development of TM.  
 
Herbal-medicinal plant interactions. 
 
Herbal medicinals are being used by an increasing number of patients who typically do not advise their clinicians of 
concomitant use. The problem of drug- herbal interaction have been an issue in Cameroon for a long time, because most 
tradi-practioners are not aware of the fact that they need to be well informed on the interaction potential of their products and 
some potential medications. Tradi-practitioners need to know what their patients are taking as drugs before any treatment can 
start (Rose et al., 1990., Asongalem et al., 2008; Samy and Gopalakrisnakone2008). Known or potential drug-herb 
interactions exist and should be screened for. It has been shown that if used beyond 8 weeks, Echinacea could cause 
hepatotoxicity and therefore should not be used with other known hepatoxic drugs, such as anabolic steroids, amiodarone, 
methotrexate, and ketoconazole (Ndhlala et al., 2009). However, Echinacea lacks the 1, 2 saturated necrine ring associated 
with hepatoxicity of pyrrolizidine alkaloids (Ndhlala et al., 2009). Nonsteroidal anti-inflammatory drugs may negate the 
usefulness of feverfew in the treatment of migraine headaches (Vivien and Faure, 1985; Stafford et al., 2008). Feverfew, 
garlic, ginkgo, ginger, and ginseng may alter bleeding time and should not be used concomitantly with warfarin sodium 
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(Sonke, 2005). Additionally, ginseng may cause headache, tremulousness, and manic episodes in patients treated with 
phenelzine sulfate (Sofowora, 1982; White and Edwards, 2000; Garrido et al., 2009). Ginseng should also not be used with 
estrogens or corticosteroids because of possible additive effects.  
 
Future prospect. 
 
There is increased interest for search for new chemical entities and the expression of resistance of many drugs  
available in the market has lead to a shift in paradigm towards medicinal research. There has been an increased interest in the 
areas of genomics and scientists in Cameroon are looking at the study of this plant not only at cellular level, but at molecular 
levels. How exposure to cells can regulate gene expression, and selection of biomarkers for different therapeutics endpoint. 
There is also the prospect of the application of nanotechnology in detecting these NCE at nano-particle. There are ongoing 
researches on testing medicinal plants for estrogenic properties detected through luciferase genes when exposed to 
immunofluorescent stained cells. 
 
Conclusion 
 
Traditional medicine occupies a very important place in health care in the world in general, in Africa and 
Cameroon in particular: In Cameroon the process to effectively develop TM is in progress due to a favourable integrated 
environmental, national and international framework set up by the Government. 
The Governments should establish the necessary institutional and financial support to promote the potential role of 
herbal medicine in primary health care delivery. Priority should be given to the development of herbal medicine by means of 
the following measures: -inventorying and documenting the various medicinal plants and herbs which are used to treat 
common diseases in each region of Cameroon; -establishing local botanical gardens for the preservation of essential 
medicinal herbal plants in different parts of each country, in order to ensure a sustainable supply of safe, effective and 
affordable medicinal herbs; -setting up testing laboratories with adequate facilities for the assessment of the efficacy of 
medicinal herbs, and establishing dosage norms for the proper administration.  
If the Cameroonian society is out to fight poverty by exploring our natural environment, then research should be focused on 
the use of plants for our welfare for it is said “a healthy man is a wealthy man”. 
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Plants Used For Malaria Treatments
Aframomum sp (Zingiberaceae)
Vernonia guineensis (Asteraceae) 
GINSENG
•Alstonia boonei
• (Apocynaceae)
•Spilanthes oleracea
• (Asteraceae)
 
Figure 1: Some selected medicinal plants used from malaria treatments (Courtesy, MEM). 
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•Destruction of medicinal 
plants through abusive 
harvesting of the bark of 
tress.
 
Figure 2: showing destruction of the forest by abusive harvesting. (Courtesy MEM)  
 
 
Barks of trees sold in local market 
medicinal plants bottled for sale
Commercialization of medicinal plants
Exhibition sales during African TM Day
 
Figure 3: Medicinal plant products on sale in local markets in Cameroon (courtesy, MEM).  
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Participatory Training initiative by the Millennium Ecological Museum 
(MEM) on basic therapeutic techniques and good preservation 
practices
 
Figure 4: Participatory training efforts of tradi-practioners in Cameroon (Courtesy MEM) 
Commercial Drugs from medicinal plants
Enantia chlorantha harvest
Emilia coccinea (Asteraceae)
Pola-Gastral-A-T-200-gastritis/gastralgiaHepasor use to treat Hepatitis  
Figure 5: Commercial drugs from local medicinal plants of Cameroon (Courtesy, MEM). 
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